Treatment of Netherton Syndrome With Abrocitinib

Chun-Chan Zheng; Xiao-Xuan Chen; Rui-Tao Zou; Gui-Yue Cai; Rong-Yi Chen

doi:10.1001/jamadermatol.2023.0561

Treatment of Netherton Syndrome With Abrocitinib

JAMA Dermatol. 2023 Jul 1;159(7):791-793. doi: 10.1001/jamadermatol.2023.0561.

Authors

Chun-Chan Zheng¹, Xiao-Xuan Chen^{1

2}, Rui-Tao Zou^{1

2}, Gui-Yue Cai^{1

2}, Rong-Yi Chen¹

Affiliations

¹ Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, China.
² Guangdong Medical University, Zhanjiang, China.

PMID: 37163259
DOI: 10.1001/jamadermatol.2023.0561

No abstract available

Plain language summary

This case report describes a 28-year-old woman with Netherton syndrome who had large erythematous migratory patches with serpiginous double-edged scales on her face, neck, trunk, and extremities.

MeSH terms

Humans
Netherton Syndrome* / diagnosis
Netherton Syndrome* / drug therapy
Pyrimidines
Sulfonamides

Substances

abrocitinib
Pyrimidines
Sulfonamides